Trials / Not Yet Recruiting
Not Yet RecruitingNCT07442292
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
PD-L1 Targeting Peptide Probe 68Ga-cPP-BCH for PET Imaging of Solid Tumor
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to construct a noninvasive approach using radiolabbled peptide 68Ga-cPP-BCH PET/CT to detect the PD-L1 expression of tumor lesion in patients with lung cancer, melanoma and other solid tumor to identify patients benefiting from anti-PD-(L)1 treatment.
Conditions
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2026-12-01
- Completion
- 2027-06-01
- First posted
- 2026-03-02
- Last updated
- 2026-03-05
Source: ClinicalTrials.gov record NCT07442292. Inclusion in this directory is not an endorsement.